Business Wire

Hyperice Unveils Next Generation of Contrast Therapy Innovation, Hyperice X 2 Knee and Hyperice X 2 Shoulder

Share

Driven by Athlete Feedback, the New Hyperice X 2 Unlocks a New Era of Contrast Recovery Tech With Powerful Multi-Level Compression

Hyperice, a global high-performance wellness brand, today announced the global launch of Hyperice X 2, the next generation of its best-selling Hyperice X contrast therapy line. Born from the acquisition of RecoverX in 2021 and refined through athlete testing, Hyperice X 2 is the most advanced portable contrast therapy device on the market. The Hyperice X 2 Knee and Hyperice X 2 Shoulder feature major upgrades from their predecessor devices, including deeper cold, stronger heat, and a built-in compression system to aid athletes and active users with more effective warm-up and recovery strategies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819036830/en/

Driven by athlete feedback, the new Hyperice X 2 unlocks a new era of contrast recovery tech with powerful multi-level compression. With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use.

Hyperice X 2 marks the most substantial evolution in technology from its first-generation product. The breakthrough innovation was built and refined through a rigorous feedback loop with elite athletes. Every detail, from contrast and compression ranges to fit and portability, has been accounted for, ensuring the product meets the demands of elite athletes on the sideline alongside everyday individuals.

“Recovery and wellness are fundamental to living well, from professional athletes to people of all ages,” said Jim Huether, CEO of Hyperice. “Our mission is to provide the most advanced and effective solutions to help people move, feel, and perform better every day. With Hyperice X 2 Shoulder and Hyperice X 2 Knee, we’re not just advancing recovery, we’re redefining it. This next generation maintains the mobility and power of its predecessor while seamlessly fusing contrast therapy and compression into a sleek, more practical design.”

With advanced technology tested and proven by athletes, Hyperice X 2 Knee and Hyperice X 2 Shoulder bring elite-level warm-up and recovery contrast therapy solutions in a new, user-friendly device designed for everyday use. Whether training, rehabbing from injury or surgery, or staying active on the go, users can prime their bodies, recover faster, and perform at their best.

Key Features:

  • Addition of compression: Five levels of compression (up to 160mmHg) push temperatures deeper into the tissue, allowing users to tailor the compression to their needs and achieve a more customized fit.
  • Targeted contrast therapy: Expanded temperature ranges now span from 40°F (4°C) to 121°F (49°C), with five levels of cooling and five levels of heating, to ease inflammation and boost circulation as needed. Up from the original Hyperice X range at 45°F (7°C) to 113°F (45°C).
  • Smart control and all-in-one mobility: A new all-in-one OLED display allows seamless switching between hot, cold, and contrast therapy, as well as select compression levels. Hyperice X 2 is cord-free for use on the move, with an option to plug in to the wall for extended rehab sessions.
  • Manual and Bluetooth compatibility: New to Hyperice X 2, users can use the device with or without Bluetooth connectivity to the Hyperice app, allowing pros to leverage the technology on the sidelines easier than ever before.
  • Extended battery life: Up to 1.5 hours of continuous portable use (1 hour on max cold, 1 hour on max contrast, and 1.5 hours on max heat) - 34% more capacity compared to the original Hyperice X line.
  • Lightweight and portable: Just 2.5 lbs and TSA-friendly, Hyperice X 2 Knee and Hyperice X 2 Shoulder prioritize portability and ease of use. Each device is designed to fit both the right and left sides, to allow for increased versatility and on-the-go therapy.

From Generation 1 to Game-Changer

Building on the success of the original Hyperice X Knee and Hyperice X Shoulder models, Hyperice X 2 uses thermoelectric systems to deliver instant heat and cold temperatures on demand, without the need for ice or liquid. Hyperice X 2 introduces a clinically inspired multi-level compression system that drives temperatures deeper into tissue, ultra-convenient on-device smart controls, and cord-free portability. Now, this athlete-endorsed technology comes in a lightweight, portable device designed to help anyone, anytime, anywhere.

“I’ve put everything into this off-season to come back stronger, and recovery is where that work pays off with the Hyperice X 2 Shoulder playing a major role in my routine,” said Jayden Daniels, Washington Commanders quarterback and Hyperice athlete. “I can push my limits on the field because the built-in compression elevates my warm-up, and the contrast therapy helps me bounce back quickly for peak performance.”

Benefits of contrast therapy include:

  • Reduces swelling and pain: Contrast moves fluid, while compression limits buildup to ease inflammation and discomfort.
  • Relaxes muscles and boosts circulation: Heat loosens tight muscles, cold calms spasms, and both, paired with compression, improve blood flow.
  • Improves range of motion: Reduces stiffness, mobilizes joints, and softens tissue for smoother, safer movement.
  • Flushes waste: Contrast and compression work together to speed up the removal of lactic acid and other byproducts.
  • Aids warm-up and recovery: Increases tissue readiness before activity and helps muscles reset and recover after.

The Hyperice X 2 Knee and Hyperice X 2 Shoulder are available now in the U.S. at hyperice.com, Best Buy, Dick’s Sporting Goods, and REI for $449. In Europe and the UK, the same cutting-edge technology will be available at hyperice.com as Hyperice Contrast 2 on September 15, retailing for £399 or €449.

Assets can be found HERE.

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), contrast therapy (Hyperice X), and Hyperboot collaboration with Nike. Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies and a TIME Best Inventions winner, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. For more information, visit hyperice.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250819036830/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting udvider platformen med tilføjelsen af Liberty IT Consulting Group fra Australien21.8.2025 18:12:00 CEST | Pressemeddelelse

Andersen Consulting styrker sine digitale transformationskompetencer yderligere med Liberty IT, der er en førende leverandør af digital transformation i virksomhedsklassen inden for finansielle services. Liberty IT, der blev grundlagt i 2016 og har hovedkontor i Australien, specialiserer sig i teknologirådgivning for førende finansielle organisationer såsom banker, formueforvaltere og børsen. Virksomheden er specialiseret inden for modernisering af banksystemer, betalingsløsninger, data og digitale løsninger med særligt fokus på implementering af cloudbaserede løsninger, systemintegration, datamigrering, programmering, DevOps, kunstig intelligens og fusioner og integrationer af virksomheder. Med et stærkt renomme på markedet samarbejder Liberty IT med kunder om at levere skalerbare platforme, øge driftsmæssig effektivitet, optimere ydeevne, reducere omkostninger, maksimere sandsynligheden for succesfuld projektlevering og accelerere digitale transformationsinitiativer. "Samarbejdet med

Veridas Identity Fraud Solutions Now Available on AWS Marketplace21.8.2025 18:05:00 CEST | Press release

Veridas, a global leader in identity verification and biometric solutions, today announced that its Identity Verification (IDV) platformis now available on Amazon Web Services (AWS) Marketplace. This launch puts the full power of Veridas’ fraud prevention and identity verification capabilities in the hands of millions of AWS customers worldwide, making secure digital trust only a click away. As identity fraud rises exponentially — with threats from synthetic identities, deepfakes, and injection attacks — Veridas delivers a cloud-native solution combining facial biometrics, AI-driven document authentication, and certified liveness detection. The platform shields enterprises from fraud while enabling seamless onboarding in seconds. “Live since 2017, our IDV platform already protects more than 300 clients in 25 countries against advanced fraud such as deepfakes and injection attacks, with 100% proprietary technology, global coverage, and international compliance,” said Eduardo Azanza, CEO

Altasciences Chosen by Steel Therapeutics to Support the Launch of Pivotal Toxicology Study for Fizurex™21.8.2025 17:21:00 CEST | Press release

Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. (“Steel”), to initiate a pivotal toxicology study for Fizurex™, a novel topical therapy for the treatment of anal fissures. The GLP-compliant study is currently being conducted at Altasciences’ preclinical facility in Columbia, MO. It marks a key milestone in Steel’s regulatory development, as the company prepares for an Investigational New Drug (IND) application in early 2026. “We’re proud to be supporting Steel Therapeutics at this key stage of their development journey,” said Steve Mason, Co-COO at Altasciences. “Our teams are aligned in their commitment to accelerate the delivery of patient-centered therapies. The initiation of this study is another example of how early collaboration and scientific rigor can bring important treatments closer to market.” Fizurex™, a patent-pending compounded wipe, has seen widespread use in clinical practice and is now progressing through the formal regulatory pathway to reach b

Media alert | Masdar receives ‘AA-’ credit rating with stable outlook by S&P Global Ratings in further recognition of the financial strength of the business21.8.2025 15:55:00 CEST | Press release

Masdar has been assigned an ‘AA-’ credit rating with a stable outlook by S&P Global Ratings, reinforcing its position as a global clean energy leader. This new rating reflects Masdar's diversified global position, strong growth prospects, and disciplined financial policies, including the allocation of green bond proceeds to finance the construction of new projects. With top credit ratings now secured from Moody’s (A1), Fitch (AA-) and S&P (AA-), Masdar continues to be recognized as one of the most financially robust renewable energy companies worldwide. This enables the Company to continue to drive responsible expansion and deliver inclusive progress across key international markets. The rating is also underpinned by the strong support of the Company's three shareholders - Abu Dhabi National Oil Company (ADNOC), Mubadala Investment Company, and Abu Dhabi National Energy Company PJSC (TAQA) - as well as the Government of Abu Dhabi. View source version on businesswire.com: https://www.bu

Verb Technology Announces $780 Million in Treasury Assets to Advance its TON Treasury Strategy21.8.2025 15:20:00 CEST | Press release

Verb Technology Company, Inc. (Nasdaq: VERB) (to be renamed Ton Strategy Company) (the “Company”) today announced treasury assets exceeding $780 million, including $713 million1 of Toncoin ($TON), the native cryptocurrency of The Open Network (“TON”) Blockchain, and $67 million of cash. This is an important milestone in the Company’s implementation of its previously announced $TON treasury strategy. Today’s news follows the Company’s August 8 closing of a $558 million private placement joined by more than 110 institutional and crypto-native investors. The Company used the majority of proceeds from the private placement to acquire $TON as its primary treasury reserve asset. "Crossing $780 million in assets just days after our private placement reflects the conviction behind $TON,” said Manuel Stotz, Executive Chairman of the Company. “This is more than building a balance sheet; it’s about contributing to the security of TON blockchain – where participants can build, transact, and benefi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye